Ovensa

Canadian, early-stage biotech developing chitosan-based nanotech drug delivery for Oncology, Neurodegenerative, and DR Infections

placeOntario, California, United States calendar_todayFounded 2012 groups3 employees language ovensa.com

Innovation

1 patent family — focus: Human necessities; filing pace dormant. Cited 2 times.

YearFilings
20191

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital133%
Angel & family office133%
Accelerator & incubator133%
Coming soon